Yang B, Li Y, Wang Y, Yang L, et al. Efficacy and Safety of Recibokibart, an Interleukin-36 Receptor Antibody, in Generalized Pustular Psoriasis: A Phase 2 Randomized Trial. Br J Dermatol 2026 Sep 3:ljag369. doi: 10.1093.
PMID: 42687756